Bioactive compounds from Rhodiola rosea (Crassulaceae)

Phytotherapy Research

Volumn 19, Issue 9, 2005, Pages 740-743

  Ming, Dong Sheng ^a,b   Hillhouse, Brian J ^a   Guns, Emma S ^a,b   Eberding, Andy ^b   Xie, Sherwin ^b   Vimalanathan, Selvarani ^a   Towers, G H Neil ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Antibacterial; Antiprostate cancer cell line; Gallic acid; Gossypetin 7 O L rhamnopyranoside; p tyrosol; Rhodioflavonoside; Rhodiola rosea; Trans p hydroxycinnamic acid

Indexed keywords

4 TYROSOL; GALLIC ACID; GOSSYPETIN 7 O LEVO RHAMNOPYRANOSIDE; PARA COUMARIC ACID; RHODIOFLAVONOSIDE; RHODIOLA EXTRACT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL FRACTIONATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG SCREENING; DRUG STRUCTURE; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PLANT STEM; PROSTATE CANCER; RHODIOLA; RHODIOLA ROSEA; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION; ULTRAVIOLET SPECTROSCOPY;

ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; HUMANS; INHIBITORY CONCENTRATION 50; MICROBIAL SENSITIVITY TESTS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; PLANT STEMS; RHODIOLA; STAPHYLOCOCCUS AUREUS;

CRASSULACEAE; RHODIOLA; RHODIOLA ROSEA; STAPHYLOCOCCUS AUREUS;

EID: 27644450797     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1597     Document Type: Article

References (30)

1. Aziza MM, Amer MM, Hassan AB, Soliman GA. 1990. Antimicrobial activity of Roemeria hybrida flavonoid glycosides. J Drug Res 19: 199-207.
2. Azizov A, Seifulla RD. 1998. The effect of elton, leveton, fitoton and adapton on the work capacity of experimental animals. Eksp Klin Farmakol 61: 61-63.
3. Darbinyan V, Kteyan A, Panossian A, Gabrielian E, Wikman G, Wagner H. 2000. Rhodiola rosea in stress induced fatigue - a double blind cross-over study of standardized extract SHR-5 with repeated low dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine 7: 365-370.
4. Fan W, Tezuka Y, Komatsu K, Namba T, Kadota S. 1999. Prolyl endopeptidase inhibitors from the underground part of Rhodiola sacra S. H. Fu. Biol Pharm Bull 22: 157-161.
5. Fan W, Tezuka Y, Ni KM, Kadota S. 2001. Prolyl endopeptidase inhibitors from the underground part of Rhodiola sachalinensis. Chem Pharm Bull 49: 396-401.
6. Furmanowa M, Skopinska-Rozewska E, Rogala E, Hartwich M. 1998. Rhodiola rosea in vitro culture-phytochemical analysis and antioxidant action. Acta Societatis Botanicorum Poloniae 67: 69-73.
7. German C, Ramazanov Z. 1999. Arctic Root of Rhodiola Rosea - The Powerful Ginseng Alternative. Kensington Press: New York.
8. Gleave ME, Hseih JT, Gao C, von Eschenbach AC, Chung LW. 1991. Acceleration of human prostate carcinoma growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res 51: 3753-3761.
9. Gleave ME, Hseih JT, Wu HC, von Eschenbach AC, Chung LWK. 1992. Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors. Cancer Res 52: 1598-1605.
10. Ip SP, Che CT, Leung PS. 2001. Association of free radicals and the tissue reninangiotensin system: prospective effects of Rhodiola, a genus of Chinese herb, on hypoxia-induced pancreatic injury. J. Pancreas (Online) 2: 16-25.
11. Kelly GS. 2001. Rhodiola rosea: a possible plant adapatogen. Altern Med Rev 6: 293-302.
12. Kurmukov AG, Aizikov MI, Rakhimov SS. 1986. Pharmacology of the plant polyphenol epigalokhin. Farmakol Toksikol 49: 45-48.
13. Lee MW, Lee YA, Park HM, et al. 2000. Antioxidative phenolic compounds from the roots of Rhodiola sachalinensis A. Bor. Arch Pharm Res 23: 455-458.
14. Linh PT, Kim YH, Hong SP, Hong SP, Jian JJ, Kang JS. 2000. Quantiative determination of salidroside and tyrosol from the underground part of Rhodiola rosea by high performance liquid chromatography. Arch Pharm Res 23: 349-352.
15. Lopez A, Ming DS, Towers GHN. 2002. Antifungal activity of benzoic acid derivatives from Piper lanceafolium. J Nat Prod 65: 62-65.
16. Maslov LN, Lishmanov YB, Maimessulova LA, Krashov EA. 1998. A mechanism of antiarrhythmic effect of Rhodiola rosea. Bull Exp Biol Med 125: 374-376.
17. Maslov LN, Lishmanov YB, Naumova AV, Lasukova TV. 1997. Do endogenous ligands of peripheral mu- and delta-opiate receptors mediate antiarrhythmic and cardioprotective effects of Rhodiola rosea. Bull Exp Biol Med 124: 754-756.
18. Ming DS, Lopez A, Hillhouse BJ, French CJ, Hudson JB, Towers GHN. 2002. Bioactive constituents from Iryanthera megistophylla. J Nat Prod 65: 1412-1416.
19. Ohsugi M, Fan W, Hase K, et al. 1999. Active-oxygen scavenging activity of traditional nourishing-tonic herbal medicines and active constituents of Rhodiola sacra. J Ethnopharmacol 67: 111-119.
20. Petkov VD, Yonkov D, Mosharoff A, et al. 1986. Effects of alcohol aqueous extract from Rhodiola rosea L. roots on learning and memory. Acta Physiol Pharmacol Bulg 12: 3-16.
21. Rege NN, Thatte UM, Dahanukar SA. 1999. Adaptogenic properties of six rasayana herbs used in Ayurvedic medicine. Phytother Res 13: 275-291.
22. Ritch-Krc EM, Turner NJ, Towers GHN. 1996. Carrier herbal medicine: an evaluation of antimicrobial and anticancer activity in some frequently used remedies. J Ethnopharmacol 52: 151-156.
23. Saito K, Oku T, Ata N, Miyashiro H, Hattori M, Saiki I. 1997. A modified convenient method for assessing tomor cell invasion and migration and its application to screening for inhibitors. Biol Pharm Bull 20: 345-348.
24. Spasov AA, Wikman GK, Mandrikov VB, Mironova IA, Neumoin VV. 2000. A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine 7: 85-89.
25. Tezuka Y, Fan W, Kasimu R, Kadota S. 1999. Screening of crude drug extracts for prolyl endopeptidase inhibitory activity. Phytomedicine 6: 197-203.
26. Udintsev SN, Schakhov VP. 1991. Decrease of cyclophosphamide haematotoxicity by Rhodiola rosea root extract in mice with Ehrlich and Lewis transplantable tumors. Eur J Cancer 27: 1182.
27. Udintsev SN, Shakhov VP. 1991. The role of humoral factors of regenerating liver in the development of experimental tumors and the effect of Rhodiola rosea extract on this process. Neoplasma 38: 323-331.
28. Yoshikawa M, Shimada H, Shimada H, Murakami N, Yamahara J, Matsuda H. 1996. Bioactive constituents of Chinese natural medicine. II. Rhodiola Radix. (1). Chemical structures and antiallergic activity of Rhodiocyanosides A and B from the underground part of Rhodiola quadrifida (pall) Fisch. Et Mey. Chem Pharm Bull 44: 2086-2091.
29. Yu WS, Chen XM, Li H, Yang L. 1993. Polyphenols from Rhodiola crenulata. Planta Med 59: 80-82.
30. Zapesochnaya GG, Kurkin VA, Shchavilinskii AN. 1985. Flavonoids of the above-ground part of Rhodiola rosea. II. Structure of novel glycosides of herbacetin and gossypetin. Khim Prir Soedin 4: 496-507.